ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
97 826,88
-0,29%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE

  6. Maxcyte Inc (MXCT) Cours

Maxcyte Inc

Maxcyte Inc (MXCT)

MaxCyte Inc
340,00
10,00
(3,03%)
Fermé 04 Janvier 5:30PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
340,00
Prix Achat
336,00
Prix Vente
344,00
Volume échangé
2 735
329,00 Fourchette du Jour 340,00
256,00 Plage de 52 semaines 420,00
Cap du marché
351,916M
Clôture Veille
330,00
Ouverture
330,00
Dernière Transaction
750
@
336
(O)
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
41 293
Actions en circulation
103 504 571
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-11,95
Bénéfice par action (BPA)
-0,37
Chiffre d'affairess
41,29M
Bénéfice net
-37,92M

À propos de Maxcyte Inc

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.maxcyte.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Maxcyte Inc est coté dans le secteur Biological Pds,ex Diagnstics de la London Stock Exchange avec le ticker MXCT. Le dernier cours de clôture d'Maxcyte était de 330,00p. Au cours de la dernière année, les actions de Maxcyte ont été négociées dans une fourchette de prix de 256,00p à 420,00p.

Maxcyte compte actuellement 103 504 571 actions en circulation. La capitalisation boursière d'Maxcyte est de £341,57 million. Maxcyte a un ratio cours/bénéfice (ratio PE) de -11.95.

MXCT Dernières nouvelles

Plus de nouvelles

MaxCyte, Inc. Total Voting Rights

MaxCyte, Inc. 02 January 2025   MaxCyte, Inc.   ("MaxCyte" or the "Company")   Total Voting Rights   ROCKVILLE, MD, January 2, 2025: MaxCyte Inc., (NASDAQ: MXCT; LSE: MXCT), a leading...

02 Janvier 2025
RNS Regulatory News

MaxCyte, Inc. Exercise of options and PDMR dealing

MaxCyte, Inc. 31 December 2024     MaxCyte, Inc. ("MaxCyte" or the "Company")   Exercise of options and PDMR dealing   ROCKVILLE, MD, December 31, 2024: MaxCyte Inc., (NASDAQ: MXCT; LSE:...

31 Décembre 2024
RNS Regulatory News

MaxCyte, Inc. MaxCyte Announces Retirement of Board Member

MaxCyte, Inc. 23 December 2024     MaxCyte Announces Retirement of Board Member Art Mandell   ROCKVILLE, MD, December 23, 2024 - MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading...

23 Décembre 2024
RNS Regulatory News

MaxCyte Announces Retirement of Board Member Art Mandell

ROCKVILLE, Md., Dec. 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...

23 Décembre 2024
GlobeNewswire Inc.

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 19 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

19 Décembre 2024
RNS Regulatory News

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 18 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

18 Décembre 2024
RNS Regulatory News

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

10 Décembre 2024
RNS Regulatory News

MaxCyte, Inc. Holding(s) in Company

MaxCyte, Inc. 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

10 Décembre 2024
RNS Regulatory News

MaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savings

MaxCyte Inc on Monday said the current year has been good for the company as it upgraded its core revenue guidance fo ...

09 Décembre 2024
Alliance News

MaxCyte, Inc. MaxCyte Streamlines Operations and Raises Guidance

MaxCyte, Inc. 09 December 2024     MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance   ROCKVILLE, MD, December 9, 2024 - MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a...

09 Décembre 2024
RNS Regulatory News
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1133.975535168232734031419742329.11671669DE
45920.996441281128134627924261319.30629613DE
125117.647058823528934625641293284.57017438DE
263110.032362459530938025625404291.46797908DE
52-37.5-9.93377483444377.542025628010333.21878982DE
156-435-56.1290322581775785172.538328402.03686319DE
260216.5175.303643725123.5123012083241568.70829551DE

MXCT - Frequently Asked Questions (FAQ)

What is the current Maxcyte share price?
The current share price of Maxcyte is 340,00p
How many Maxcyte shares are in issue?
Maxcyte has 103 504 571 shares in issue
What is the market cap of Maxcyte?
The market capitalisation of Maxcyte is GBP 341,57M
What is the 1 year trading range for Maxcyte share price?
Maxcyte has traded in the range of 256,00p to 420,00p during the past year
What is the PE ratio of Maxcyte?
The price to earnings ratio of Maxcyte is -11,95
What is the cash to sales ratio of Maxcyte?
The cash to sales ratio of Maxcyte is 10,98
What is the reporting currency for Maxcyte?
Maxcyte reports financial results in USD
What is the latest annual turnover for Maxcyte?
The latest annual turnover of Maxcyte is USD 41,29M
What is the latest annual profit for Maxcyte?
The latest annual profit of Maxcyte is USD -37,92M
What is the registered address of Maxcyte?
The registered address for Maxcyte is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Maxcyte website address?
The website address for Maxcyte is www.maxcyte.com
Which industry sector does Maxcyte operate in?
Maxcyte operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
TCFTheracryf Plc
0,725p
(38,10%)
7,56M
NMTNeometals Ltd
3,50p
(27,27%)
346,81k
SCHOScholium Group Plc
44,00p
(25,71%)
30,65k
FABFusion Antibodies Plc
10,15p
(24,54%)
3,34M
PYXPyx Resources Limited
3,49p
(22,24%)
8,43k
TM1Technology Minerals Plc
0,125p
(-24,24%)
37,21M
QUIZQuiz Plc
0,70p
(-18,60%)
3,67M
SYMESupply@me Capital Plc
0,003p
(-17,81%)
168,35M
OBDOxford Biodynamics Plc
1,20p
(-14,29%)
827,83k
ZENZenith Energy Ltd.
5,25p
(-13,93%)
5,39M
TRPTower Resources Plc
0,0395p
(5,33%)
539,51M
CPXCap-xx Limited
0,1825p
(1,39%)
494M
NTVONativo Resources Plc
0,0019p
(0,00%)
320,16M
DGIDg Innovate Plc
0,0225p
(-13,46%)
208,21M
ENETEthernity Networks Ltd
0,1125p
(2,27%)
207,56M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

LSE
MXCT
Maxcyte
BOV
ITUB3Q
ITAU UNIBANCO ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés